Biotechnology Reports (Jun 2024)

Characterization of plant produced VHH antibodies against cobra venom toxins for antivenom therapy

  • Sarocha Vitayathikornnasak,
  • Kaewta Rattanapisit,
  • Ashwini Malla,
  • Pipob Suwanchaikasem,
  • Richard Strasser,
  • Narach Khorattanakulchai,
  • Kanokporn Pothisamutyothin,
  • Wanatchaporn Arunmanee,
  • Waranyoo Phoolcharoen

Journal volume & issue
Vol. 42
p. e00841

Abstract

Read online

Cobra (Naja kaouthia) venom contains many toxins including α-neurotoxin (αNTX) and phospholipase A2 (PLA2), which can cause neurodegeneration, respiratory failure, and even death. The traditional antivenom derived from animal serum faces many challenges and limitations. Heavy-chain-only antibodies (HCAb), fusing VHH with human IgG Fc region, offer advantages in tissue penetration, antigen binding, and extended half-life. This research involved the construction and transient expression of two types of VHH-FC which are specific to α-Neurotoxin (VHH-αNTX-FC) and Phospholipase A2 (VHH-PLA2-FC) in Nicotiana benthamiana leaves. The recombinant HCAbs were incubated for up to six days to optimize expression levels followed by purification by affinity chromatography and characterization using LC/Q-TOF mass spectrometry (MS). Purified proteins demonstrated over 92 % sequence coverage and an average mass of around 82 kDa with a high-mannose N-glycan profile. An antigen binding assay showed that the VHH-αNTX-Fc has a greater ability to bind to crude venom than VHH-PLA2-Fc.

Keywords